Tribeca Venture Partners

Tribeca Venture Partners

Partners Chip Meakem and Brian Hirsch launched Tribeca Venture Partners as a New York-centric early-stage venture firm during a period when the city's startup infrastructure was still maturing. Meakem brought operating and investing experience from Longworth Venture Partners, while Hirsch had built his career as a venture investor at Sterling Partners and Time Warner Ventures. They anchored the firm downtown, deliberately choosing proximity to both Wall Street and the creative class. The firm invests at the seed and Series A stages, typically leading or co-leading rounds with initial checks calibrated to give founders meaningful runway. While software and enabling technologies form the core of the portfolio, Tribeca has backed companies across financial services infrastructure, healthcare IT, and media platforms. The firm maintains a disciplined reserve strategy, earmarking capital for follow-on rounds to defend ownership positions as companies scale. Direct co-investment alongside established venture partnerships is common, and the firm has syndicated deals with top-tier coastal funds seeking New York-based deal anchors. Tribeca Venture Partners has deployed capital across multiple funds, though exact AUM and team size are not publicly disclosed. The firm's early bets included companies that became foundational to New York's tech corridor. In recent years, the firm has remained active in the pre-seed and seed ecosystem, participating in competitive rounds where local presence and founder relationships provide an edge. Operating from offices in Lower Manhattan, the firm's network leverages connections across financial services, media, and advertising technology sectors — industries where New York holds structural advantages over Silicon Valley. Unlike many early-stage firms that scale headcount with assets, Tribeca Venture Partners operates as a deliberately lean partnership. This structure concentrates decision-making with the founding partners, who maintain direct, active board roles across the portfolio. The model mirrors a family office's patient capital posture more than an institutional venture platform chasing rapid AUM growth.